Healthcare · Pharmaceuticals & Biotechnology
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).
Ranks #None of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 7 May 2026 | SWATI AGARWALA | Bulk | Sell | 66,000 | 168.7800 | BSE |
| 6 May 2026 | SWATI AGARWALA | Bulk | Sell | 105,000 | 166.0000 | BSE |
| 26 Nov 2025 | PADMAWATI REALCON PRIVATE LIMITED | Bulk | Buy | 70,000 | 150.4100 | BSE |
| 26 Nov 2025 | NU HEIGHTS AGENCY PRIVATE LIMITED | Bulk | Buy | 90,000 | 149.5900 | BSE |
| 24 Nov 2025 | VIVEKGUJRANI | Bulk | Buy | 5,000 | 139.9900 | BSE |
| 24 Nov 2025 | VIVEKGUJRANI | Bulk | Sell | 54,000 | 118.7300 | BSE |
| 12 Nov 2025 | BASAN EQUITY BROKING LIMITED | Bulk | Sell | 54,000 | 140.0200 | BSE |
| 3 Jun 2025 | CRAFT EMERGING MARKET FUND PCC- ELITE CAPITAL FUND | Bulk | Sell | 58,000 | 136.2100 | BSE |
| 3 Jun 2025 | CARAVAN PROPERTIES PRIVATE LIMITED | Bulk | Buy | 62,000 | 137.5300 | BSE |
| 3 Jun 2025 | ASTORNE CAPITAL VCC ARVEN | Bulk | Sell | 85,000 | 137.4900 | BSE |
Exchange disclosures (NSE and BSE), most recent first.
| Date | Category | Announcement |
|---|---|---|
| 25 Sep 2026 | Insider Trading / SAST | Astonea Labs Ltd - 544409 - Closure of Trading Window |
| 19 Sep 2026 | Result | Astonea Labs Ltd - 544409 - Resubmission Of Financial Results For The Financial Year Ended 31.03.2025 In Response To BSE Communication |
| 18 Sep 2026 | Insider Trading / SAST | Astonea Labs Ltd - 544409 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 |
| 9 Sep 2026 | Company Update | Astonea Labs Ltd - 544409 - Appointment Of Internal Auditor |
| 9 Sep 2026 | Others | Astonea Labs Ltd - 544409 - Board Meeting Outcome for Meeting Held On 9Th September, 2026. |
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
